Newly synthesized lysosomal enzymes are equipped with mannose 6-phosphate residues that are recognized by specific receptors (MPR) 1 mediating their transport to lysosomes. The segregation of soluble hydrolases from the secretory route is believed to occur in the trans-Golgi network. Receptor-ligand complexes are packed in clathrin-coated vesicles that fuse with an acidified endosomal/prelysosomal compartment. Following the pH-induced dissociation of complexes, the enzymes are transferred to lysosomes, whereas receptors recycle to the Golgi for further rounds of transport or to the cell surface. Two mannose 6-phosphate-specific receptors with molecular masses of 46 (MPR 46) and 300 kDa are known (1, 2) . Both MPRs are type I integral membrane glycoproteins that differ in their developmental expression pattern (3), subcellular localization (4, 5) , quaternary structure (6, 7), half-life of the receptor protein (7, 8) , ligand binding properties, and function (9 -14) .
Several signal structures have been identified in the cytoplasmic tail of MPR 46 needed for trafficking between internal membranes and the plasma membrane. A di-leucine motif localized in the carboxyl-terminal region of MPR 46 is required for efficient sorting in the trans-Golgi network (15) . These leucine residues (Leu 64 -Leu 65 ) also contribute to rapid internalization of MPR 46 together with two other independent signals (Phe 13 and Phe 18 , as well as Tyr 45 ) in the 67-amino acid tail (16, 17) . For the transport of MPR 46 to the plasma membrane, phosphorylation of Ser 57 has been shown to be critical (18) .
Recently, it was reported that the substitution of Cys 34 in the cytoplasmic tail resulted in accumulation of mutant MPR 46 in dense lysosomes (19) resembling MPR 46 mutants with deleted residues 34 -39 (20) . Because Cys 30 and Cys 34 are reversibly palmitoylated, which may anchor the tail to the lipid bilayer, it has been speculated that a critical conformation of the cytoplasmic tail is required to prevent the delivery of MPR 46 to lysosomes (19) .
In the present study we investigated the importance of spacing between the proposed palmitoylated anchor site at Cys 34 in the cytoplasmic tail and the transmembrane domain for stability and trafficking of MPR 46. It has been shown that the spacing of the tyrosine-based sorting motif in the cytoplasmic tail of lamp1 relative to the transmembrane domain is crucial for delivery to dense lysosomes (21) . We analyzed MPR 46 mutants in which the length of the potentially intracellular loop was changed. The deletion of residues 20 -23 or 24 -29 resulted in rapid degradation of MPR 46, which could be decreased by respective alanine substitutions. Although lysosomal protease inhibitors impaired the degradation of a small percentage of the deletion mutants, the proteasome inhibitor lactacystin almost completely prevented the degradation of the MPR 46 mutants.
MATERIALS AND METHODS
[ 35 S]Methionine (100 Ci/mmol), [ 3 H]palmitic acid (40 -60 Ci/mmol), and Na 125 I were purchased from Amersham Pharmacia Biotech. NAcetyl-Leu-Leu-norleucinal (ALLN) was obtained from Sigma, lactacystin was from Biomol (Hamburg, Germany), and Pansorbin (10% Staphylococcus aureus cell suspension) was from Calbiochem.
Oligonucleotides were synthesized by Nucleic Acids Products Supply (Göttingen/Germany). The rabbit antiserum, an affinity-purified goat IgG against the human liver MPR 46, the rabbit antiserum (MSC-1) against the cytoplasmic tail of MPR 46, and the monoclonal anti-MPR 46 antibody (21D3) have been described previously (5, 22, 23 DNA Constructs-Human MPR 46 cDNA was kindly provided by Dr. Regina Pohlmann (this institute) and subcloned into pUC19 restricted with BamHI. MPR 46 deletion mutants ⌬20 -23, ⌬24 -29, and ⌬50 -54 (corresponding to residues 230 -233, 234 -239, and 260 -264 of the fulllength human MPR 46, respectively) were described previously (24) . Alanine substitution (Ala 24 -29 ) was carried out by inversed polymerase chain reaction procedure amplifying the entire plasmid using GCA GCT GCA TGT GAL TTT GTC TGC CG and AGC TGC AGC GCC AAG ATC CTG CCA GAA GGC (the replaced alanine codons are underlined) as internal primers. The mutation was verified by sequencing with an ABI sequencer model 373 A.
Cell Culture and Transfection-Baby hamster kidney (BHK) cells (clone BHK 21) were maintained in Dulbecco's modified Eagle's medium supplemented with 5% (v/v) fetal calf serum and penicillin/streptomycin. The cells were transfected with 15 g of plasmid DNA and 1 g of resistance plasmids using the calcium phosphate technique as described previously (18, 24) . Stable colonies selected for resistance against neomycin were isolated and screened for MPR 46 expression by 21D3 antibody binding (23) ]palmitic acid (300 Ci/ml) for 4 h and chased for up to 22 h followed by immunoprecipitation of MPR 46 and analysis by SDS-PAGE and fluorography as described (18) or by phosphoimaging (Fujix BAS 1000, Fuji Photo Co.). The radiolabeled polypeptides were quantified by densitometric scanning (Hewlett Packard Scan Jet 4c IT) or by phosphoimaging, respectively
Other Methods-Continuous uptake at 37°C and internalization of MPR 46-specific 125 I-labeled antibodies 21D3 prebound to cell surfaces at 4°C were carried out as described (25) . After removal of cell surfaceassociated radioactivity by an acid wash step at pH 2.5, the cells were solubilized in 1 N NaOH, and the cell-associated radioactivity was determined with respect to cell protein (26) . Percoll density gradient fractionation was performed with a postnuclear supernatant derived from cells grown in a 10-cm dish as described (27) . After removal of Percoll, the membrane fractions were solubilized, and proteins were separated by SDS-PAGE (10% acrylamide) followed by transfer onto nitrocellulose membranes. MPR 46 were detected using the MSC-1 antibody (1:300) and the ECL Super Signal system (Pierce).
RESULTS

Deletion Mutants MPR 46 ⌬20 -23 and ⌬24 -29 Are Rapidly
Degraded-The palmitoylation of Cys 34 and the presence of aromatic residues at positions 18 and 19 contribute to the stability of the MPR 46 by preventing its accumulation in lysosomes (19, 28) . To analyze the importance of the spacing between the palmitoylation site and the transmembrane domain, MPR 46 mutants with deletions of residues 20 -23 and 24 -29 were stably expressed in BHK cells. When cells were labeled with [ 35 S]methionine for 3 h and then chased for up to 36 h followed by immunoprecipitation of receptors, SDS-PAGE, and fluorography or autoradiography, the half-life of the wild type MPR 46 was calculated to be Ͼ30 h (Ref. 29 and Fig. 1 ). In contrast, the half-lives of MPR 46 ⌬20 -23 and ⌬24 -29 were reduced to 9 -10 h and less than 10 h, respectively. In three independent experiments the average half-life was determined to be 7 h (Fig. 1B) . Deletion of five carboxyl-terminal amino acids (MPR 46 ⌬50 -54) did not affect the receptor half-live (Fig. 1A) . The replacement of residues 24 -29 by alanine (MPR 46 A24 -29) resulted in a prolongation of receptor stability compared with the deletion mutant ⌬24 -29 (t1 ⁄2 Ӎ ϳ 20 h; see MPR 46 ⌬24 -29 Is Not Degraded in Lysosomes-Percoll density gradient fractionation was used to demonstrate the accumulation of unstable MPR 46 mutants in dense lysosomes (19, 21) . When BHK cells expressing the mutant MPR 46 ⌬24 -29 were pretreated for 24 h with leupeptin/pepstatin A (each 100 M) followed by fractionation of postnuclear supernatants on Percoll density gradients and analysis by Western blotting, the mutant MPR 46 was recovered almost completely in light membrane fractions (Fig. 2) . The majority of ␤-hexosaminidase activity was found in dense fractions 1-3. These data were confirmed by pulse-chase experiments carried out in the presence of lysosomal protease inhibitors leupeptin/pepstatin A. Pretreatment of cells with these protease inhibitors increased the amount of mutant MPR 46 ⌬20 -23 and MPR 46 A24 -29 by 5% (Fig. 3A) . The amount of MPR 46 ⌬24 -29 recovered after a chase of 18 h in the presence of leupeptin/pepstatin A was estimated to be 30% compared with 18% from cells incubated in the absence of inhibitors (Fig. 3B) . In contrast, the peptide aldehyde inhibitor ALLN retarded the degradation of MPR 46 ⌬24 -29 about 3-fold. Lactacystin, a more specific, irreversible proteasome inhibitor (30) was much more potent than ALLN in inhibition of MPR 46 ⌬24 -29 degradation, resulting in values of recovered mutant MPR 46 comparable with the wild type receptor. The effect of lactacystin on MPR 46 ⌬24 -29 degradation was maximal at 5 M. Addition of lactacystin during the pulse and chase period did not affect the amount of recovered 35 S-labeled MPR A24 -29 (Fig. 3C) . Treatment of BHK cells for 15 h with 10 M lactacystin showed toxicity effects like rounding up and partial detaching of cells. In addition, the presence of 10 M lactacystin during the pulse period decreased the [ MPR 46 Deletion Mutants Are Not Degraded in Endoplasmic Reticulum-To define the site of mutant MPR 46 degradation, MPR 46 ⌬20 -23 expressing cells were either pulse-labeled and chased at 15 or 20°C, inhibiting the transport of newly synthesized proteins at a pre-Golgi site and proximal to the trans Golgi, respectively (31, 32) . After incubation at 15°C for 8 h, the newly synthesized immature MPR 46 were completely endoglucosaminidase H-sensitive, indicating that receptors were accumulated at a pre-Golgi compartment. (Fig. 4) . During a chase period of 5 h at 20°C about 50% of MPR 46 acquired oligosaccharides resistant to endoglucosaminidase H, indicating the transport to the mid/trans Golgi. The presence of lactacystin did not increase the amount of MPR 46 ⌬20 -23 mutants pulse-chased under these conditions (Fig. 4) . However, when the cells were shifted to 37°C for 3 h, all MPR 46 ⌬20 -23 acquired endoglucosaminidase H-resistant oligosaccharides, and lactacystin increased the amount of immunoprecipitated receptors by 39% as determined by densitometry. From these data it can be concluded that the majority of mutant endoglucosaminidase H-resistant MPR 46 are degraded in a lactacystin-dependent manner after leaving the Golgi compartment.
Palmitoylation of Mutant MPR 46 -To determine whether the deletion of residues 20 -23 or 24 -29 results in inhibition of palmitoylation, which was shown to lead to endosomal missorting (19) To determine whether deletions or substitution of amino acids in the cytoplasmic tail affects the transport of MPR 46 to the plasma membrane, the uptake of 125 I-labeled 21D3 antibodies was measured at 37°C. Fig. 6 shows that the amount of endocytosed Postnuclear supernatants were prepared and subjected to Percoll density gradient centrifugation. The gradients were fractionated from the bottom in 11 fractions and fractions 1-3, 4 -6, and 7-9 were combined into pools I, II, and III, respectively. After removal of Percoll, the membranes were solubilized and analyzed by SDS-PAGE and immunoblotting using the MSC-1 antibody and ECL. The subcellular distribution of ␤-hexosaminidase activity is given below the lanes as percentage of the total activity recovered. WT, wild type. clones tested, indicating that the substitution of six alanine residues impaired the transport to the plasma membrane while the internalization was not effected.
DISCUSSION
The results presented in this article demonstrate that deletions of 4 or 6 amino acids in the putative cytoplasmic loop between the transmembrane domain and the palmitoylated site at Cys 34 cause rapid degradation of MPR 46. The degradation is insensitive to inhibitors of lysosomal proteases but can be prevented by lactacystin, the most specific proteasome inhibitor known so far. In addition, the degradation of mutant MPR 46 appears to be a post-Golgi event.
Previously it was shown that palmitoylation of Cys 34 anchoring the cytoplasmic domain of MPR 46 to the lipid bilayer may mask a sorting signal that directs the receptor from endosomes to lysosomes followed by degradation (19, 20) . The diaromatic Phe 18 -Trp 19 motif has been identified as key residues for sorting in endosomes (28) facilitated by the binding of the cytosolic protein TIP 47 (33) . Our present data indicate that the precise spacing between transmembrane domain and lipid anchor is also critical for MPR 46 sorting. However, the lack of mutant MPR 46 ⌬24 -29 accumulation in dense lysosomal fractions and the failure of lysosomal protease inhibitors to protect newly synthesized mutant receptors from degradation suggest that in the presence of the diaromatic Phe 18 -Trp 19 endosomal sorting motif mutant MPR 46 are degraded by other nonlysosomal proteolytic systems.
A clear inhibition of degradation of mutant MPR 46 is caused by the proteasomal inhibitors ALLN and lactacystin. Proteasomes have been implicated in the degradation of unfolded or unassembled proteins retained in the endoplasmic reticulum as well as in down-regulation of endoplasmic reticulum-resident proteins as part of feed back control (34 -36) . After covalent attachment of ubiquitin, these membrane or soluble proteins appear to be retranslocated to the cytosol involving the sec61 complex (37). We could not detect any specific ubiquitinmodified mutant MPR 46 by Western blotting, 2 which is consistent with findings that certain proteins do not require ubiquitination for proteasomal degradation (38, 39) . The low temperature experiments and the degradation of mature MPR 46 mutants containing complex type, endoglucosaminidase Hresistant oligosaccharides indicate that the majority of mutant MPR 46 is degraded after leaving the Golgi while the intracel- lular site for degradation of MPR 46 ⌬20 -23 or ⌬24 -29 is still unknown. Furthermore, the impaired transport to the plasma membrane of mutant MPR 46 A24 -29 suggests that these residues may be involved in the (endosomal) sorting process. The data cannot exclude the possibility that trafficking of mutant MPR 46 is altered due to decreased palmitoylation. It is likely that only 40% of receptors reached compartments in which palmitoylation of Cys 34 occur and residual receptors are retained in an organelle for degradation. The mechanism of the lactacystin-sensitive degradation of MPR 46 in a post-Golgi compartment remains to be examined. At present, serine phosphorylation has been documented to trigger regulated degradation of ubiquitin-modified proteins by the proteasome (40, 41) .
